Immunofluorescence-Based Antiviral Assay for SARS-CoV-2

It will be a long period of SARS-CoV-2 vaccine or antiviral therapies development. Thus repositioning of evaluated drugs plays important role in the rapid identification and deployment of treatments for COVID-19. Compared with common validation methods, the immunofluorescence-based antiviral assay could provide more information for the viruses that replicate rapidly, like SARS-CoV-2. With a comprehensive technology platform and a team of professional experts, Creative Biolabs provides global researchers with high-quality immunofluorescence-based antiviral assay to support the development of therapeutics of SARS-CoV-2.

Immunofluorescence-Based Antiviral Assay

The immunofluorescence-based antiviral assay is an alternative method for antiviral assay. This method requires small volumes thus allow multiple replicates, dilutions, or conditions. With fewer steps, it spends shorter times than TCID50 and has lower variability. The whole process is under a physiological condition, therefore, the assay provides the opportunity to look at morphological changes within the cell, or at sites of viral replication. In addition, this immunofluorescence-based antiviral assay allows high flexibility for cell line choice (both adherent or in suspension cell lines are practicable) and magnification (from 4× to 63×). For viruses with rapid replication kinetics like SARS-CoV-2, the immunofluorescence-based antiviral assay is more reliable and informative.

Fig.1 Brief workflow of the immunofluorescence-based antiviral assay.

Services at Creative Biolabs

Focus on vaccine development and antiviral research for years, Creative Biolabs has accumulated extensive experience from practice. To make a contribution to the control of the COVID-19 pandemic, we have established a comprehensive platform to study SARS-CoV-2. With advanced technologies, mature technicians, professional Ph.D. level experts, and rich experience, we are capable of offering reliable SARS-CoV-2 assay services.

The immunofluorescence-based antiviral assay has multi advantages for SARS-CoV-2 detection. To support global researchers promote the development of SARS-CoV-2 therapies, Creative Biolabs offers reliable immunofluorescence-based antiviral assay. If you are interested in the immunofluorescence-based antiviral assay, please feel free to contact us for more information.

For Research Use Only. We do not provide direct services or products for patients.